Model
Edge
Alnylam Pharmaceuticals, Inc.
0001557290
Filing type
4
Filing date
Jan 6, 2026
Updated
Jan 7, 2026 ยท 2:17 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership